| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_029116ee41eeec8a03f88a8cddbaa758 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0039
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2210-0004
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-9528
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0041 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-148
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-0077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90 |
| filingDate |
2015-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36faafd6514457460ad18d252231a13a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efc53359af81c7f2fc59ca75ec22f4e6 |
| publicationDate |
2017-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3128960-A1 |
| titleOfInvention |
Partially coated stents |
| abstract |
A medical product comprises a biodegradable filament (110) and a non-biodegradeable coating (112). The biodegradable filament forms a stent body (100) having a first end portion (104), a middle portion (108), and a second end portion (106) opposite the first end portion. The middle portion extends between the first and second end portions. The non-biodegradeable coating encapsulates the at least one biodegradable filament along the middle portion of the stent body. The non-biodegradeable coating forms a barrier such that the non-biodegradeable coating prevents degradation of the at least one biodegradable filament along the middle portion. The first and second end portions are uncoated. After implantation, the end portions of the stent may biodegrade. The middle portion will not biodegrade due to its encapsulation by the non-biodegradeable coating. |
| priorityDate |
2014-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |